Deerfield Special Situations Fund, L.P.

10% owner at PAR PHARMACEUTICAL COMPANIES, INC. · on record since Feb 1, 2007
10% owner at INSPIRE PHARMACEUTICALS INC · on record since May 2, 2007
10% owner at CORAUTUS GENETICS INC · on record since Aug 24, 2007
10% owner at DYNAVAX TECHNOLOGIES CORP · on record since Jul 23, 2007
10% owner at DUSA PHARMACEUTICALS INC · on record since Nov 27, 2007
10% owner at EMAGEON INC · on record since Nov 27, 2007
10% owner at ANADYS PHARMACEUTICALS INC · on record since Oct 25, 2007
10% owner at NeurogesX Inc · on record since Mar 31, 2008
10% owner at XCYTE THERAPIES INC · on record since Mar 14, 2008
10% owner at NITROMED INC · on record since May 6, 2008
10% owner at NeuroMetrix, Inc. · on record since Dec 5, 2008
10% owner at NxStage Medical, Inc. · on record since Jun 19, 2009
Possible Member of 10% Group at eHealth, Inc. · on record since Mar 9, 2015
10% owner at NOVELLUS SYSTEMS INC · on record since Jun 16, 2015
10% owner at LANVISION SYSTEMS INC · on record since Jul 13, 2015
*Possible member of 10% group at FLAMEL TECHNOLOGIES SA · on record since Jun 25, 2018
Possible Member of a 10% Group at Aclaris Therapeutics, Inc. · on record since Dec 27, 2018

Insider trading activity of Deerfield Special Situations Fund, L.P.

Transactions on record: 228; since Mar 30, 2006

Open-market buys: 81; $54.9M

Open-market sells: 112; $17.3M

Companies traded: 20; last filing Feb 12, 2019

Figures computed from official regulatory filings — .

Companies where Deerfield Special Situations Fund, L.P. has traded

2 tx · $109.3K · Feb 12, 2019
1 tx · Jan 2, 2019
10 tx · $6M · Jul 25, 2016
1 tx · $601K · Jun 16, 2016
18 tx · $13.7M · Dec 18, 2015
12 tx · $2M · Dec 8, 2015
1 tx · $1.9M · Sep 22, 2015
12 tx · $3.7M · Nov 25, 2014
27 tx · $31.9M · Aug 5, 2014
40 tx · $6.8M · May 7, 2012
16 tx · $840.9K · Mar 22, 2011
8 tx · $5.8M · Dec 13, 2010
6 tx · $70.1K · Oct 28, 2010
13 tx · $1.5M · Sep 16, 2009
6 tx · $146.1K · Nov 14, 2008

Track record of Deerfield Special Situations Fund, L.P.

Statistical track record

Free

Open-market buys: 85

Last buy: Jul 25, 2016

Win rates and median returns are available with a free account (5 insiders/month).

Transaction history of Deerfield Special Situations Fund, L.P.

Co-insiders of Deerfield Special Situations Fund, L.P.

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
Xeris Biopharma Holdings, Inc.	Feb 12, 2019	Sell	-5,890	15.11 USD	$89K	SEC
Xeris Biopharma Holdings, Inc.	Feb 12, 2019	Sell	-1,351	15.00 USD	$20.3K	SEC
Aclaris Therapeutics, Inc.	Jan 2, 2019	OtherD (derivative)	1	—	—	SEC
Audentes Therapeutics, Inc.	Jul 25, 2016	OtherD (derivative)	-99,830	—	—	SEC
Audentes Therapeutics, Inc.	Jul 25, 2016	OtherD (derivative)	-267,998	—	—	SEC
Audentes Therapeutics, Inc.	Jul 25, 2016	Other	99,830	—	—	SEC
Audentes Therapeutics, Inc.	Jul 25, 2016	OtherD (derivative)	-535,996	—	—	SEC
Audentes Therapeutics, Inc.	Jul 25, 2016	OtherD (derivative)	-99,830	—	—	SEC
Audentes Therapeutics, Inc.	Jul 25, 2016	Buy	253,404	15.00 USD	$3.8M	SEC
Audentes Therapeutics, Inc.	Jul 25, 2016	Buy	146,596	15.00 USD	$2.2M	SEC
Audentes Therapeutics, Inc.	Jul 25, 2016	Other	267,998	—	—	SEC
Audentes Therapeutics, Inc.	Jul 25, 2016	Other	99,830	—	—	SEC
Audentes Therapeutics, Inc.	Jul 25, 2016	Other	535,996	—	—	SEC
eHealth, Inc.	Jun 16, 2016	Sell	-43,300	13.88 USD	$601K	SEC
Vanda Pharmaceuticals Inc.	Dec 18, 2015	Buy	128,374	8.61 USD	$1.1M	SEC
Vanda Pharmaceuticals Inc.	Dec 18, 2015	Buy	100,864	8.61 USD	$868.4K	SEC
Vanda Pharmaceuticals Inc.	Dec 18, 2015	Buy	93,634	8.61 USD	$806.2K	SEC
Vanda Pharmaceuticals Inc.	Dec 18, 2015	Buy	40,997	8.59 USD	$352.2K	SEC
Vanda Pharmaceuticals Inc.	Dec 18, 2015	Buy	29,902	8.59 USD	$256.9K	SEC
Vanda Pharmaceuticals Inc.	Dec 18, 2015	Buy	32,211	8.59 USD	$276.7K	SEC
Vanda Pharmaceuticals Inc.	Dec 11, 2015	Buy	100,864	8.61 USD	$868.4K	SEC
Vanda Pharmaceuticals Inc.	Dec 11, 2015	Buy	11,506	9.00 USD	$103.6K	SEC
Vanda Pharmaceuticals Inc.	Dec 11, 2015	Buy	93,634	8.61 USD	$806.2K	SEC
Vanda Pharmaceuticals Inc.	Dec 11, 2015	Buy	229,833	8.21 USD	$1.9M	SEC
Vanda Pharmaceuticals Inc.	Dec 11, 2015	Buy	40,997	8.59 USD	$352.2K	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Xeris Biopharma Holdings, Inc.	Feb 12, 2019	Sell	-5,890	15.11 USD	$89K	SEC
Xeris Biopharma Holdings, Inc.	Feb 12, 2019	Sell	-1,351	15.00 USD	$20.3K	SEC
Aclaris Therapeutics, Inc.	Jan 2, 2019	OtherD (derivative)	1	—	—	SEC
Audentes Therapeutics, Inc.	Jul 25, 2016	OtherD (derivative)	-99,830	—	—	SEC
Audentes Therapeutics, Inc.	Jul 25, 2016	OtherD (derivative)	-267,998	—	—	SEC
Audentes Therapeutics, Inc.	Jul 25, 2016	Other	99,830	—	—	SEC
Audentes Therapeutics, Inc.	Jul 25, 2016	OtherD (derivative)	-535,996	—	—	SEC
Audentes Therapeutics, Inc.	Jul 25, 2016	OtherD (derivative)	-99,830	—	—	SEC
Audentes Therapeutics, Inc.	Jul 25, 2016	Buy	253,404	15.00 USD	$3.8M	SEC
Audentes Therapeutics, Inc.	Jul 25, 2016	Buy	146,596	15.00 USD	$2.2M	SEC
Audentes Therapeutics, Inc.	Jul 25, 2016	Other	267,998	—	—	SEC
Audentes Therapeutics, Inc.	Jul 25, 2016	Other	99,830	—	—	SEC
Audentes Therapeutics, Inc.	Jul 25, 2016	Other	535,996	—	—	SEC
eHealth, Inc.	Jun 16, 2016	Sell	-43,300	13.88 USD	$601K	SEC
Vanda Pharmaceuticals Inc.	Dec 18, 2015	Buy	128,374	8.61 USD	$1.1M	SEC
Vanda Pharmaceuticals Inc.	Dec 18, 2015	Buy	100,864	8.61 USD	$868.4K	SEC
Vanda Pharmaceuticals Inc.	Dec 18, 2015	Buy	93,634	8.61 USD	$806.2K	SEC
Vanda Pharmaceuticals Inc.	Dec 18, 2015	Buy	40,997	8.59 USD	$352.2K	SEC
Vanda Pharmaceuticals Inc.	Dec 18, 2015	Buy	29,902	8.59 USD	$256.9K	SEC
Vanda Pharmaceuticals Inc.	Dec 18, 2015	Buy	32,211	8.59 USD	$276.7K	SEC
Vanda Pharmaceuticals Inc.	Dec 11, 2015	Buy	100,864	8.61 USD	$868.4K	SEC
Vanda Pharmaceuticals Inc.	Dec 11, 2015	Buy	11,506	9.00 USD	$103.6K	SEC
Vanda Pharmaceuticals Inc.	Dec 11, 2015	Buy	93,634	8.61 USD	$806.2K	SEC
Vanda Pharmaceuticals Inc.	Dec 11, 2015	Buy	229,833	8.21 USD	$1.9M	SEC
Vanda Pharmaceuticals Inc.	Dec 11, 2015	Buy	40,997	8.59 USD	$352.2K	SEC